Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

SEC Filing · 15-12G

SCPHARMACEUTICALS INC

SEC Filing

Filed Oct 17, 2025Accepted Oct 17, 2025, 11:40 AM EDTCIK 1604950Accession 0001193125-25-242425
Share

Company context

Historical securities (1)

Recent company filings

  1. SCHEDULE 13G/A - filed by Weiss Asset Management LP regarding scPharmaceuticals Inc.Feb 11, 2026
  2. EFFECT filingNov 19, 2025
  3. EFFECT filingNov 19, 2025
  4. EFFECT filingNov 19, 2025
  5. SCHEDULE 13G - filed by Weiss Asset Management LP regarding scPharmaceuticals Inc.Nov 12, 2025

As-filed source

Primary evidence